Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -29.69M
December 31, 2024 -22.35M
December 31, 2023 -47.18M
December 31, 2022 -75.96M
Date Value
December 31, 2021 -52.54M
December 31, 2020 -32.17M
December 31, 2019 -25.00M
December 31, 2018 -14.48M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Integra LifeSciences Holdings Corp. 50.38M
Abbott Laboratories 9.566B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 45.23M
AtriCure, Inc. 57.33M